FPR2 enhances colorectal cancer progression by promoting EMT process.

In conclusion our study demonstrated that FPR2 can promote CRC cells progression in vitro and in vivo that may relate to promoting EMT. PMID: 31288528 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31288528?dopt=Abstract

Source: Neoplasma - June 16, 2019 Category: Cancer & Oncology Authors: Lu J, Zhao J, Jia C, Zhou L, Cai Y, Ni J, Ma J, Zheng M, Lu A Tags: Neoplasma Source Type: research